{"id":27998,"date":"2017-04-20T15:12:44","date_gmt":"2017-04-20T13:12:44","guid":{"rendered":"http:\/\/www.invarena.cz\/?p=27998"},"modified":"2017-04-20T15:12:44","modified_gmt":"2017-04-20T13:12:44","slug":"dostupna-biosimilarni-biologicka-lecba-vraci-nemocne-do-zivota","status":"publish","type":"post","link":"https:\/\/www.invarena.cz\/?p=27998","title":{"rendered":"Dostupn\u00e1 biosimil\u00e1rn\u00ed biologick\u00e1 l\u00e9\u010dba vrac\u00ed nemocn\u00e9 do \u017eivota"},"content":{"rendered":"<p><strong>Biologick\u00e1 l\u00e9\u010dba je v p\u0159\u00edpad\u011b st\u0159evn\u00edch z\u00e1n\u011bt\u016f, onkologick\u00fdch, revmatologick\u00fdch, ale i dal\u0161\u00edch onemocn\u011bn\u00ed vysoce efektivn\u00ed, z\u00e1rove\u0148 je v\u0161ak velmi n\u00e1kladn\u00e1, co\u017e limituje jej\u00ed dostupnost. Zm\u011bnit tuto situaci m\u016f\u017ee zav\u00e1d\u011bn\u00ed biosimil\u00e1rn\u00edch p\u0159\u00edpravk\u016f, kter\u00e9 jsou stejn\u011b kvalitn\u00ed, bezpe\u010dn\u00e9 a maj\u00ed stejn\u00e9 \u00fa\u010dinky jako jejich origin\u00e1ln\u00ed biologick\u00e9 p\u0159edlohy. D\u00edky ni\u017e\u0161\u00ed cen\u011b ale \u010din\u00ed l\u00e9\u010dbu dostupn\u011bj\u0161\u00ed pro v\u00edce lid\u00ed, kte\u0159\u00ed ji pot\u0159ebuj\u00ed.<\/strong> <!--more--><\/p>\n<p>\u010cesk\u00e9 zdravotnictv\u00ed vyu\u017e\u00edv\u00e1 biosimil\u00e1rn\u00ed l\u00e9\u010dbu ji\u017e des\u00e1t\u00fdm rokem a ze z\u00e1kona je \u00fahrada tzv. biosimilars automaticky o 30 % ni\u017e\u0161\u00ed. Pro vy\u0161\u0161\u00ed informovanost pacient\u016f se ned\u00e1vno spustil web dostupnalecba.cz.<\/p>\n<p>Biologick\u00e1 l\u00e9\u010dba je nejefektivn\u011bj\u0161\u00ed formou l\u00e9\u010dby \u0159ady z\u00e1n\u011btliv\u00fdch onemocn\u011bn\u00ed, v l\u00e9\u010debn\u00e9m procesu v\u0161ak stoj\u00ed obvykle na sam\u00e9m konci. D\u016fvodem je vysok\u00e1 cena. Ta je v\u0161ak kompenzov\u00e1na efektem terapie, v\u010detn\u011b dramatick\u00e9ho zv\u00fd\u0161en\u00ed kvality \u017eivota nemocn\u00fdch.<\/p>\n<p>Umo\u017e\u0148uj\u00ed l\u00e9\u010dit tis\u00edce pacient\u016f nav\u00edc<\/p>\n<p>\u00da\u010dinn\u00e1, kvalitn\u00ed, bezpe\u010dn\u00e1 a p\u0159edev\u0161\u00edm levn\u011bj\u0161\u00ed. Takov\u00e1 je c\u00edlen\u00e1 l\u00e9\u010dba s vyu\u017eit\u00edm biosimil\u00e1rn\u00edch p\u0159\u00edpravk\u016f. Biosimil\u00e1rn\u00ed p\u0159\u00edpravky (tak\u00e9 biosimilars) jsou biologick\u00e9 l\u00e9ky vytvo\u0159en\u00e9 jako kopie origin\u00e1ln\u00edho biologick\u00e9ho l\u00e9\u010diva po vypr\u0161en\u00ed jeho patentov\u00e9 ochrany (kter\u00e1 trv\u00e1 20 let). Jedn\u00e1 se tedy o l\u00e1tky sv\u00fdmi vlastnostmi velice podobn\u00e9 t\u011bm, kter\u00e9 se vyu\u017e\u00edvaj\u00ed v origin\u00e1ln\u00ed c\u00edlen\u00e9 l\u00e9\u010db\u011b. V\u00edce ne\u017e desetilet\u00e1 zku\u0161enost, kterou m\u00e1 evropsk\u00e1 medic\u00edna s biosimilars, ukazuje, \u017ee jejich kvalita, \u00fa\u010dinnost i bezpe\u010dnost je shodn\u00e1 s origin\u00e1ln\u00edmi l\u00e9ky. Nejv\u00edce jsou v sou\u010dasnosti vyu\u017e\u00edvan\u00e9 v gastroenterologii, onkologii a revmatologii, vyu\u017eit\u00ed ale najdou i v \u0159ad\u011b dal\u0161\u00edch obor\u016f (nap\u0159. nefrologii).<\/p>\n<p>&#8222;Zav\u00e1d\u011bn\u00ed biosimil\u00e1rn\u00ed l\u00e9\u010dby znamen\u00e1 z\u00e1sadn\u00ed zlom v dostupnosti p\u00e9\u010de pro pacienty s \u0159adou z\u00e1va\u017en\u00fdch chorob, v\u010detn\u011b st\u0159evn\u00edch z\u00e1n\u011bt\u016f. Vysok\u00e1 cena biologick\u00e9 l\u00e9\u010dby toti\u017e \u0159\u00e1dov\u011b p\u0159evy\u0161uje cenu obdobn\u00e9 l\u00e9\u010dby chemick\u00fdmi (konven\u010dn\u00edmi) l\u00e9\u010divy, i proto je po\u010det pacient\u016f l\u00e9\u010den\u00fdch biologickou terapi\u00ed st\u00e1le ni\u017e\u0161\u00ed, ne\u017e by odpov\u00eddalo skute\u010dn\u00e9 pot\u0159eb\u011b. Nap\u0159\u00edklad zaveden\u00edm biosimil\u00e1rn\u00edho infliximabu jsme mohli v \u010cR za\u010d\u00edt l\u00e9\u010dit o 2000 pacient\u016f s IBD (st\u0159evn\u00edmi z\u00e1n\u011bty) v\u00edce,&#8220; \u0159\u00edk\u00e1 gastroenterolog Martin Bortl\u00edk.<\/p>\n<p>L\u00e9\u010dba pomoc\u00ed biosimilars nen\u00ed \u017e\u00e1dn\u00fd experiment nebo hazard. Podm\u00ednky pro vstup t\u011bchto l\u00e9\u010div na trh jsou pevn\u011b d\u00e1ny sm\u011brnicemi Evropsk\u00e9 l\u00e9kov\u00e9 agentury (EMA). Na rozd\u00edl od generik chemick\u00fdch l\u00e9\u010div je u nich nutn\u00e9 prov\u00e1d\u011bt srovn\u00e1vac\u00ed studie s &#8222;referen\u010dn\u00edm p\u0159\u00edpravkem&#8220;, kter\u00e9 prokazuj\u00ed, \u017ee biosimil\u00e1rn\u00ed l\u00e9k je skute\u010dn\u011b kvalitn\u00ed, bezpe\u010dn\u00fd a \u00fa\u010dinn\u00fd produkt.<\/p>\n<p>Biologickou terapii dost\u00e1v\u00e1 jen 12 % pacient\u016f<\/p>\n<p>Jednou z oblast\u00ed, kde biologick\u00e1 l\u00e9\u010dba a biosimilars nach\u00e1zej\u00ed sv\u00e9 m\u00edsto, jsou z\u00e1n\u011btliv\u00e1 st\u0159evn\u00ed onemocn\u011bn\u00ed (IBD). Jenom s nimi je v \u010cesku hospitalizov\u00e1no v\u00edce ne\u017e 10 tis\u00edc pacient\u016f ro\u010dn\u011b. Celkov\u00fd po\u010det pacient\u016f s t\u011bmito chorobami u n\u00e1s se odhaduje zhruba na 42 tis\u00edc. IBD postihuj\u00ed p\u0159edev\u0161\u00edm mlad\u00e9 lidi v produktivn\u00edm v\u011bku, a je tak d\u016fle\u017eit\u00e1 nejen jejich v\u010dasn\u00e1 diagnostika, ale i efektivn\u00ed l\u00e9\u010dba.<\/p>\n<p>&#8222;V\u00fdskyt IBD v \u010cesku se zvy\u0161uje. Crohnova choroba postihuje asi 20 tis\u00edc pacient\u016f, ulcer\u00f3zn\u00ed kolitida v\u00edce ne\u017e 22 tis\u00edc lid\u00ed. Biologickou terapii p\u0159itom dost\u00e1v\u00e1 jen asi 5 tis\u00edc z nich, tedy p\u0159ibli\u017en\u011b 12 %. Ve vysp\u011bl\u00fdch evropsk\u00fdch zem\u00edch je tento pod\u00edl p\u0159ibli\u017en\u011b dvojn\u00e1sobn\u00fd, l\u00e9\u010deno je asi 25 % pacient\u016f. Biologika p\u0159itom vrac\u00ed chronicky nemocn\u00e9 a \u010dasto invalidn\u00ed pacienty do \u017eivota, a to v\u010detn\u011b jejich schopnosti pracovat. \u00dasp\u011b\u0161n\u00e1 terapie je tak ekonomicky prosp\u011b\u0161n\u00e1 pro celou spole\u010dnost,&#8220; dod\u00e1v\u00e1 Martin Bortl\u00edk.<\/p>\n<p>Dostupn\u00e1 l\u00e9\u010dba m\u00e1 i psychick\u00fd efekt<\/p>\n<p>Onemocn\u011bn\u00ed, jako jsou IBD, ovliv\u0148uj\u00ed nejen fyzick\u00fd stav \u010dlov\u011bka, ale velmi v\u00fdrazn\u011b i jeho psychiku. Jejich \u010dast\u00fdm n\u00e1sledkem je ztr\u00e1ta p\u0159irozen\u00e9ho \u017eivotn\u00edho rytmu, ztr\u00e1ta zam\u011bstn\u00e1n\u00ed nebo stud, kter\u00e9 mohou spole\u010dn\u011b s v\u011bdom\u00edm, \u017ee se jedn\u00e1 o nevyl\u00e9\u010diteln\u00e1 onemocn\u011bn\u00ed, v\u00e9st a\u017e k soci\u00e1ln\u00ed izolaci a depres\u00edm. S t\u00edm v\u0161\u00edm souvisej\u00ed i dal\u0161\u00ed specifick\u00e1 fyziologick\u00e1 onemocn\u011bn\u00ed.<\/p>\n<p>&#8222;Z\u00e1ludnost n\u011bkter\u00fdch chronick\u00fdch nemoc\u00ed tkv\u00ed i v tom, \u017ee nejsou na prvn\u00ed pohled vid\u011bt a lid\u00e9 se o nich boj\u00ed mluvit. Je to rozd\u00edl nap\u0159\u00edklad od situace, kdy je \u010dlov\u011bk upout\u00e1n na invalidn\u00ed voz\u00edk a nemus\u00ed na sv\u016fj handicap ve chv\u00edli, kdy je to nutn\u00e9, s\u00e1m upozor\u0148ovat. Sn\u00ed\u017een\u00ed kvality \u017eivota je p\u0159itom srovnateln\u00e9. \u00da\u010dinn\u00e1 l\u00e9\u010dba m\u00e1 proto z\u00e1sadn\u00ed vliv i na psychick\u00fd stav nemocn\u00fdch, kvalita jejich \u017eivota se dramaticky zvy\u0161uje,&#8220; vysv\u011btluje psychoterapeutka Karin \u0158eh\u00e1kov\u00e1.<\/p>\n<p>Porad\u00ed i najde l\u00e9ka\u0159e<\/p>\n<p>Pacient\u016fm s v\u00fd\u0161e zm\u00edn\u011bn\u00fdmi onemocn\u011bn\u00edmi i jejich p\u0159\u00edbuzn\u00fdm \u010di zn\u00e1m\u00fdm m\u00e1 uleh\u010dit nov\u011b spu\u0161t\u011bn\u00fd web dostupnalecba.cz. Tam najdou nejen aktu\u00e1ln\u00ed informace o v\u00fdvoji biologick\u00e9 a biosimil\u00e1rn\u00ed l\u00e9\u010dby a odkazy na zaj\u00edmav\u00e9 informace, ale tak\u00e9 poradnu, kde budou odborn\u00edci odpov\u00eddat na jejich dotazy a dok\u00e1\u017e\u00ed v p\u0159\u00edpad\u011b pot\u0159eby odk\u00e1zat na m\u00edsto, kde najdou konkr\u00e9tn\u00ed informaci \u010di pomoc. Z\u00e1rove\u0148 je na webu k dispozici i p\u0159ehledn\u00e1 mapa. V t\u00e9 z\u00e1jemci najdou informace o m\u00edstech, kde je tento druh l\u00e9\u010dby dostupn\u00fd.<\/p>\n<p>Pra\u017esk\u00fd patriot<br \/>\n<a href=\"http:\/\/www.prazskypatriot.cz\/\">http:\/\/www.prazskypatriot.cz\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<div class=\"mh-excerpt\"><p>Biologick\u00e1 l\u00e9\u010dba je v p\u0159\u00edpad\u011b st\u0159evn\u00edch z\u00e1n\u011bt\u016f, onkologick\u00fdch, revmatologick\u00fdch, ale i dal\u0161\u00edch onemocn\u011bn\u00ed vysoce efektivn\u00ed, z\u00e1rove\u0148 je v\u0161ak velmi n\u00e1kladn\u00e1, co\u017e limituje jej\u00ed dostupnost. Zm\u011bnit <a class=\"mh-excerpt-more\" href=\"https:\/\/www.invarena.cz\/?p=27998\" title=\"Dostupn\u00e1 biosimil\u00e1rn\u00ed biologick\u00e1 l\u00e9\u010dba vrac\u00ed nemocn\u00e9 do \u017eivota\">[&#8230;]<\/a><\/p>\n<\/div>","protected":false},"author":1,"featured_media":15438,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9],"tags":[],"class_list":["post-27998","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-zpravy"],"_links":{"self":[{"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/posts\/27998","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=27998"}],"version-history":[{"count":0,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/posts\/27998\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=\/wp\/v2\/media\/15438"}],"wp:attachment":[{"href":"https:\/\/www.invarena.cz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=27998"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=27998"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.invarena.cz\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=27998"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}